Disseminated intravascular coagulation
- PMID: 15149867
- DOI: 10.1016/j.cccn.2004.02.015
Disseminated intravascular coagulation
Abstract
The diagnosis of disseminated intravascular coagulation (DIC) was initially based on the detection of microthrombi. Current diagnosis involves laboratory assessment of hemostatic abnormalities although additional studies may often be necessary. DIC is characterized by hypercoagulability and hyperfibrinolysis and is caused by high offense factors or low defense factors. DIC is divided two stages: overt-DIC and non-overt-DIC. The diagnosis of overt-DIC state is based on the criteria developed by the International Society of Thrombosis Haemostasis in conjunction with the Japanese Ministry Health and Welfare. However, no criteria are currently available for the diagnosis of non-overt DIC. Although scientifically supported modalities for treatment of DIC are few, the use of activated protein C (APC) and low-molecular-weight heparin appear to hold promise.
Copyright 2004 Elsevier B.V.
Similar articles
-
Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC.Am J Hematol. 2003 Sep;74(1):17-22. doi: 10.1002/ajh.10377. Am J Hematol. 2003. PMID: 12949885
-
[Diagnosis of DIC based on evidence].Rinsho Byori. 2006 Nov;54(11):1172-7. Rinsho Byori. 2006. PMID: 17240840 Review. Japanese.
-
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.Br J Haematol. 2009 Apr;145(1):24-33. doi: 10.1111/j.1365-2141.2009.07600.x. Epub 2009 Feb 12. Br J Haematol. 2009. PMID: 19222477
-
Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.Thromb Haemost. 2008 Dec;100(6):1099-105. Thromb Haemost. 2008. PMID: 19132236
-
Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response.Semin Thromb Hemost. 1996;22(1):69-88. doi: 10.1055/s-2007-998993. Semin Thromb Hemost. 1996. PMID: 8711492 Review.
Cited by
-
From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis.Pathogens. 2023 Jul 24;12(7):969. doi: 10.3390/pathogens12070969. Pathogens. 2023. PMID: 37513817 Free PMC article. Review.
-
Efficacy and Safety of Recombinant Human Soluble Thrombomodulin in Patients With Sepsis-Induced Disseminated Intravascular Coagulation After Emergency Surgery.Cureus. 2025 Mar 14;17(3):e80589. doi: 10.7759/cureus.80589. eCollection 2025 Mar. Cureus. 2025. PMID: 40230734 Free PMC article.
-
Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.Medicine (Baltimore). 2018 Nov;97(44):e12981. doi: 10.1097/MD.0000000000012981. Medicine (Baltimore). 2018. PMID: 30383650 Free PMC article.
-
Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity.Thromb J. 2016 Jan 14;14:1. doi: 10.1186/s12959-016-0076-2. eCollection 2016. Thromb J. 2016. PMID: 26770073 Free PMC article.
-
Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa.Thromb J. 2021 Feb 25;19(1):12. doi: 10.1186/s12959-021-00264-z. Thromb J. 2021. PMID: 33632246 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources